J. Horti

发表

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.

I. Tannock, N. James, S. Oudard, 2004, The New England journal of medicine.

Augmentation of melanoma-specific gene expression using a tandem melanocyte-specific enhancer results in increased cytotoxicity of the purine nucleoside phosphorylase gene in melanoma.

H. Alexander, J. Horti, S. Raje, 1999, Human gene therapy.

Inhibition of EGFR tyrosine-kinase in NSCLC treatment: the Hungarian experience with gefitinib in the context of an expanded access programme.

J. Horti, G. Ostoros, L. Geczi, 2005, Anticancer research.

A randomized, double-blind, placebo-controlled phase II study of vandetanib plus docetaxel/prednisolone in patients with hormone-refractory prostate cancer.

I. Bodrogi, A. Stenzl, J. Horti, 2009, Cancer biotherapy & radiopharmaceuticals.

Concern about cancer in women undergoing elective gynaecological surgery.

A. Steptoe, J. Horti, S. Stanton, 1986, Social science & medicine.

©1999 Cancer Research Campaign Article no. bjoc.1998.0253

C. Logothetis, W. Figg, E. Reed, 2022 .

Results of salvage retroperitoneal lymphadenectomy (RLA) in the treatment of patients with nonseminomatous germ cell tumours remaining marker positive after inductive chemotherapy

I. Bodrogi, J. Horti, P. Tenke, 2007, International Urology and Nephrology.

A Phase II Trial of Gallium Nitrate in Patients with Androgen-Metastatic Prostate Cancer

E. Sausville, A. Senderowicz, W. Figg, 1999, Urologia internationalis.

Methods for extracting and amplifying genomic DNA isolated from frozen serum

William D. Figg, Eddie Reed, W. Figg, 1998, Nature Biotechnology.

A phase II study of bromocriptine in patients with androgen-independent prostate cancer.

O. Sartor, W. Figg, J. Horti, 1998, Oncology reports.

[Effect of imatinib treatment of gastrointestinal stromal tumors].

G. Bodoky, J. Horti, L. Trón, 2003, Orvosi hetilap.

Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancer

E. Juhász, I. Bodrogi, J. Horti, 2008, Cancer Chemotherapy and Pharmacology.

Prostate cancer screening.

J. Horti, B. Kovács, P. Tenke, 2007, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Enhanced activity of estramustine, vinblastine, etoposide, and suramin in prostate carcinoma.

W. Figg, J. Horti, S. Dixon, 1999, Neoplasma (Bratislava).

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.

I. Tannock, N. James, S. Oudard, 2004, New England Journal of Medicine.